Skip to main content
Premium Trial:

Request an Annual Quote

Roche, ABI Settle PCR Patent-Infringement Suit Against Bio-Rad

NEW YORK, Feb. 13 (GenomeWeb News) - Roche Molecular Diagnostics and Applied Biosystems have settled their PCR-based lawsuit with MJ Research, the companies said today.


Under the settlement, Bio-Rad, which acquired MJ Research in 2004, will make an undisclosed payment to Roche Diagnostics and ABI to settle all outstanding patent-infringement claims.


Applera and Roche Molecular Systems sued MJ Research in the US District Court for the District of Connecticut in June 1998. A jury decided in favor of Applera and Roche in 2004. Bio-Rad acquired MJ in August of that year.  


In September, Applera announced that the court had issued a permanent injunction prohibiting Bio-Rad from manufacturing, selling, or servicing infringing thermal cycler products in the US -- despite Bio-Rad's claim that the companies had settled the suit on Aug. 29.


Two months later, the court denied a motion from MJ to "enforce" the settlement agreement, and Bio-Rad said that it planned to appeal the court's decision.


Roche Diagnostics and ABI said today that the court rejected all challenges to the enforceability of Roche's PCR patents and its licensing program.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.